Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Trial of Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients With DLBCL

NCT03072771 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT03072771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03072771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Trial of Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients With DLBCL
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Completed
Start date
August 1, 2017
Completion date
October 30, 2023
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b cell lymphoma